New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review

New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review

A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking. Therefore, we investigated the demographics, management, and prognosis of new R-IMIDs in adults following SARS-CoV-2 vaccinations....

Full description

Bibliographic Details
Main Authors: Arvind Nune, Victor Durkowski, S. Sujitha Pillay, Bhupen Barman, Helen Elwell, Kaustubh Bora, Syed Bilgrami, Sajid Mahmood, Nasarulla Babajan, Srinivasan Venkatachalam, Lesley Ottewell, Ciro Manzo
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Vaccines
Subjects:
COVID-19 vaccines
rheumatic disease
immune-mediated inflammatory disease
vasculitis
connective tissue diseases
inflammatory arthritis
Online Access:https://www.mdpi.com/2076-393X/11/10/1571

Internet

https://www.mdpi.com/2076-393X/11/10/1571

Similar Items